Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Martek earnings

This article was originally published in The Tan Sheet

Executive Summary

Sales of non-infant life'sDHA formula products more than doubled in the third quarter ended, July 31, helping to drive net revenues (excluding manufacturing sales) up 12.3% to $74.5 mil., Martek announces Sept. 5. Martek customers launched eight food and beverage products and two pregnancy and nursing products containing the firm's life'sDHA ingredient in the May-July period, the Columbia, Md.-based company notes. Infant formula sales advanced 7% to $66 mil., the firm notes. Results also were boosted by the company's focus on international growth, which the firm has targeted along with increases in non-infant product sales (1"The Tan Sheet" June 18, 2007, p. 5). Net income in the quarter increased 32.7% to $6.1 mil...

You may also be interested in...

Martek Touts Non-Infant Formula Sales, Looks Globally For Formula Growth

Martek Biosciences' fiscal 2007 second-quarter sales grew 9 percent to $76.7 million, including a record $5.3 million in non-infant formula product sales, the firm said June 6

More Top-Level Pharma Changes In India, Cipla Gets CSO

Top-level personnel movement continues at pharma firms in India, with Cipla now appointing an ex-Amneal executive as its Chief Scientific Officer, while Abbott has effected a rejig at the helm.

India Acts To Limit Supply Disruption From Coronavirus

Indian pharmaceutical companies will soon be asked to seek a no objection certificate for the export of 12 APIs and their formulations, as the country deals with Chinese raw material supply disruptions on the back of the coronavirus crisis. However, the move is not expected to impact the export quantum for now.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts